傳分佈式業務擬分拆,天合光能(688599.SH)跳水跌超12%
格隆匯12月6日丨天合光能午後快速下跌,目前跌超12%。網傳截圖顯示,天合光能在投資者交流羣迴應“分佈式業務是否分拆”稱,公司始終以最有利於業務發展(包括更好的發展分佈式業務)為最高指導原則;並稱有關事項請以公司公吿為準,勿輕信市場傳言,目前公司董事會沒有收到任何關於分佈式業務分拆的指導意見。注:天合光能半年報顯示,2022年上半年公司分佈式光伏業務系統出貨量超2.2GW,成為公司新業績增長點。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.